Finalists revealed for IW Specialist Investment Awards 2016

Active and passive categories

clock • 4 min read

Investment Week is pleased to announce the finalists for our second Specialist Investment Awards, which will take place on Friday 21 October at the Banking Hall, London.

These awards are designed to recognise two increasingly important elements of the asset management industry; boutique & specialist fund managers and passive investing. They will be judged using a combination of quantitative and qualitative analysis using independent performance data from Morningstar, FE and Lipper, and input from a judging panel of leading fund analysts and researchers. Our judges for the active categories are: Jake Moeller, head of UK & Ireland research, Lipper; James de Bunsen, co-manager of the Henderson Alternative Strategies Trust; Ben Willis, investment manager/...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot